Neuro-oncology
Neuro-oncology is a medical specialty that focuses on the study, diagnosis and treatment of cancers of the brain and spinal cord, also called the central nervous system (CNS). Cancers of the CNS include primary tumors, which arise in the CNS, and secondary tumors, which have spread to the CNS from other areas of the body. These cancers can cause serious mental and physical impairments and may be life-threatening.
The neuro-oncology specialists and support staff at UK HealthCare collaborate with the oncology experts at UK HealthCare’s Markey Cancer Center to apply their extensive expertise to quickly evaluate CNS cancers in adults and children. They then implement individualized treatment plans that encompass a full range of conventional treatment options, the latest advanced therapies and clinical trials.
Neuro-oncology Specialties
The UK HealthCare neuro-oncology program takes a multidisciplinary, team approach to the complex management of a wide variety of CNS cancers including:
- Brain tumors, including gliomas (astrocytomas, oligodendrogliomas and ependymomas), meningiomas, acoustic neuromas/vestibular schwannomas and medulloblastomas
- Spinal tumors
- Neurofibromatosis, a rare genetic disorder that causes tumors to form on nerves
- Pituitary & skull base disorders
Why choose UK HealthCare for Neuro-oncology?
UK HealthCare is a nationally renowned academic medical center with a passion for providing exceptional medical care with a compassionate touch. A respected leader in clinical care, education and research, UK HealthCare is recognized for excellence.
For numerous years, UK HealthCare has been named the No. 1 Hospital in Kentucky by U.S. News & World Report in 2019. In addition, 155 UK HealthCare physicians are on the Best Doctors in America® List for 2019, more than any other Kentucky hospital. Just 4% of American doctors receive this prestigious professional honor — based on impartial peer review by other doctors.
